Clinical trial
An Open-label Effectiveness Study of a Typhoid Conjugate Vaccine in Kisantu, Democratic Republic of Congo (TyVECO) - Step 3: Surveillance Protocol
NCT05562102 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Effectiveness Study of a Typhoid Conjugate Vaccine in Kisantu, Democratic Republic of Congo (TyVECO) - Step 3: Surveillance Protocol
- Lead sponsor
- International Vaccine Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 9, 2021
- Completion date
- March 31, 2024
- Enrollment
- 48,000 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.